Close
Back to ONCS Stock Lookup

Oncosec Medical (ONCS) – Hot FDA News

Oct 19, 2017 06:06 AM Oncosec Medical (ONCS) Reports Positive Phase 2 Data for ImmunoPulse® IL-12 in Combination with Pembrolizumab
Oct 10, 2017 08:03 AM Oncosec Medical (ONCS) Commences Clinical Trial KEYNOTE-695 of ImmunoPulse IL-12 in Combination with Merck's (MRK) KEYTRUDA (pembrolizumab)
Feb 27, 2017 06:14 AM
Sep 28, 2015 07:25 AM

Back to ONCS Stock Lookup